Avexa Limited

Nicholas Andrew Van De Graff

John Joseph Deadman

David Ian Rhodes

Eric Dale Jones

Lisa Jane Winfield

Neeranat Thienthong

Giang Thanh Le

Jonathan Alan Victor Coates

Neil Choi

William Issa

Katherine Macfarlane

Neeranat Theinthong

The present invention provides a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. Further provided is a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. A pharmaceutical composition or medicament comprising a compound of Formula I is also provided. 

Bicyclic pyrimidinones and uses thereof

The present invention provides a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. The present invention further provides a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. Pharmaceutical compositions comprising a compound of formula (I) are also provided.

Compounds having antiviral properties

The present invention provides a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. The present invention further provides a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. Pharmaceutical compositions comprising a compound of formula (I) are also provided. 

Imidazopyrimidines and uses thereof

Growing community of inventors

Prahran, Australia

Nicholas Andrew Van De Graff